We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+14.87%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$594M
AUM Growth
+$85.7M
Cap. Flow
+$21.7M
Cap. Flow %
3.65%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMPR
IMPRIVATA, INC COM
IMPR
+$7.88M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$5.93M
3
CYNO
Cynosure, Inc. Class A
CYNO
+$817K
4
STAA icon
STAAR Surgical
STAA
+$238K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 52.7%
2 Consumer Staples 40.13%
3 Miscellaneous 5.89%
4 Technology 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.5B
$238M 40.13%
19,189,632
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$121M 20.37%
1,619,968
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$263M
$82.8M 13.95%
27,090,249
+1,982,419
+8% +$5.93M
STAA icon
4
STAAR Surgical
STAA
$1.14B
$61.7M 10.4%
8,646,923
+29,361
+0.3% +$238K
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$41M 6.9%
916,975
+21,520
+2% +$817K
IWM icon
6
iShares Russell 2000 ETF
IWM
$76.1B
$28.2M 4.74%
250,000
– –
IMPR
7
DELISTED
IMPRIVATA, INC COM
IMPR
$7.55M 1.27%
+668,526
New +$7.88M
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$6.45M 1.09%
1,641,025
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Broadwood Capital held 9 positions worth $594M, up 17% from $508M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital deployed $21.7M of net new capital in Q4 2015, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was IMPRIVATA, INC COM: 668,526 shares worth $7.55M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 52% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital's largest Q4 2015 buy was IMPRIVATA, INC COM: 668,526 shares worth $7.55M.
  • Broadwood Capital added most to Lineage Cell Therapeutics in Q4 2015, an estimated $5.93M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $594M portfolio in Q4 2015.
  • Broadwood Capital opened 2 new positions and closed 0 in Q4 2015.
  • Broadwood Capital's portfolio value rose 17% quarter-over-quarter to $594M.

Based on Broadwood Capital's 13F filing for Q4 2015, filed 16 Feb 2016.